Navis G - Search Results

1

ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats.

Hamming I, Navis G, Kocks MJ, van Goor H. Hamming I, et al. Among authors: navis g. J Pathol. 2006 May;209(1):129-39. doi: 10.1002/path.1956. J Pathol. 2006. PMID: 16532430

2

Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.

Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D. Wapstra FH, et al. Among authors: navis g. Clin Sci (Lond). 1996 May;90(5):393-401. doi: 10.1042/cs0900393. Clin Sci (Lond). 1996. PMID: 8665777

3

ACE inhibitors and the kidney. A risk-benefit assessment.

Navis G, Faber HJ, de Zeeuw D, de Jong PE. Navis G, et al. Drug Saf. 1996 Sep;15(3):200-11. doi: 10.2165/00002018-199615030-00005. Drug Saf. 1996. PMID: 8879974 Review.

4

Prognostic value of the short-term antiproteinuric response to ACE inhibition for prediction of GFR decline in patients with nondiabetic renal disease.

Wapstra FH, Navis G, de Jong PE, de Zeeuw D. Wapstra FH, et al. Among authors: navis g. Exp Nephrol. 1996;4 Suppl 1:47-52. Exp Nephrol. 1996. PMID: 9001897 Review.

5

ACE polymorphism does not determine short-term renal response to ACE-inhibition in proteinuric patients.

van der Kleij FG, Navis GJ, Gansevoort RT, Heeg JE, Scheffer H, de Zeeuw D, de Jong PE. van der Kleij FG, et al. Among authors: navis gj. Nephrol Dial Transplant. 1997;12 Suppl 2:42-6. Nephrol Dial Transplant. 1997. PMID: 9269699

6

Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.

van der Kleij FG, Schmidt A, Navis GJ, Haas M, Yilmaz N, de Jong PE, Mayer G, de Zeeuw D. van der Kleij FG, et al. Among authors: navis gj. Kidney Int Suppl. 1997 Dec;63:S23-6. Kidney Int Suppl. 1997. PMID: 9407415 Clinical Trial.

7

Optimizing the renal response to ace inhibition: a strategy toward more effective long-term renoprotection.

Navis G, de Jong PE, de Zeeuw D. Navis G, et al. Adv Nephrol Necker Hosp. 1997;27:57-66. Adv Nephrol Necker Hosp. 1997. PMID: 9408442 Review. No abstract available.

8

The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide.

Buter H, Hemmelder MH, Navis G, de Jong PE, de Zeeuw D. Buter H, et al. Among authors: navis g. Nephrol Dial Transplant. 1998 Jul;13(7):1682-5. doi: 10.1093/ndt/13.7.1682. Nephrol Dial Transplant. 1998. PMID: 9681711

9

Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable.

de Boer E, Navis G, Wapstra FH, de Jong PE, de Zeeuw D. de Boer E, et al. Among authors: navis g. Kidney Int Suppl. 1999 Jul;71:S42-6. Kidney Int Suppl. 1999. PMID: 10412735 Free article.

10

Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis.

Wapstra FH, van Goor H, de Jong PE, Navis G, de Zeeuw D. Wapstra FH, et al. Among authors: navis g. J Pharmacol Toxicol Methods. 1999 Apr-Jun;41(2-3):69-73. doi: 10.1016/s1056-8719(99)00015-5. J Pharmacol Toxicol Methods. 1999. PMID: 10598677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

792 results

Search Page

Filters